




已閱讀5頁(yè),還剩12頁(yè)未讀, 繼續(xù)免費(fèi)閱讀
版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
TheAntihypertensiveandLipid LoweringTreatmenttoPreventHeartAttackTrial ALLHATstudyoverviewDouble blind randomizedtrialtodeterminewhethertheoccurrenceoffatalCHDornonfatalMIislowerforhigh riskhypertensivepatientstreatedwithneweragents amlodipine lisinopril ordoxazosin comparedwithadiuretic chlorthalidone Cohort42 418patients 55yearsold from623sitesinNorthAmericaStage1or2hypertension1additionalriskfactorforCHDComparisonsbetweenchlorthalidoneandamlodipineandchlorthalidoneandlisinoprilhavebeenreportedtogether excludingthedoxazosinarm n 9 062 whichwasterminatedearly ALLHATResearchGroup JAMA 2002 288 2981 2997 www hypertensiononline org CHD coronaryheartdisease MI myocardialinfarction ALLHATStudyDesign n 13 8542 235 16 1 stoppeddrug Chlorthalidonen 15 255 Amlodipinen 9 048 Randomizedn 42 418 n 15 255339 2 2 losttofollow up80 0 5 refusedfollow up n 9 048200 2 2 losttofollow up58 0 6 refusedfollow up n 6 2101 873 30 2 stoppeddrug n 9 054218 2 4 losttofollow up58 0 6 refusedfollow up n 8 2151 357 16 5 stoppeddrug n 3 7691 052 27 9 stoppeddrug YEAR1 n 8 1581 842 22 6 stoppeddrug n 3 6051 399 38 8 stoppeddrug Lisinopriln 9 054 YEAR5 ALLHATResearchGroup JAMA 2002 288 2981 2997 www hypertensiononline org Intent to TreatAnalysis Doxazosinn 9 062 Discontinuedearlyat3 3yrs ALLHATEndpoints PrimaryendpointCompositeoffatalcoronaryheartdisease CHD ornonfatalmyocardialinfarction MI Otherpredefinedendpointsall causemortalitystrokecombinedCHD nonfatalMI CHDdeath coronaryrevascularization hospitalizedanginacombinedcardiovasculardisease combinedCHD stroke lowerextremityrevascularization treatedangina fatal hospitalized treatedcongestiveheartfailure hospitalizedoroutpatientperipheralarterialdiseaseother renal ALLHATResearchGroup JAMA 2002 288 2981 2997 www hypertensiononline org ALLHATBaselineCharacteristics ALLHATResearchGroup JAMA 2002 288 2981 2997 www hypertensiononline org BP bloodpressureCHD coronaryheartdisease ALLHATMeanSystolicandDiastolicBloodPressureDuringFollow up SystolicBP mmHg Follow up yrs DiastolicBP mmHg Chlorthalidone Amlodipine Lisinopril Chlorthalidone Amlodipine Lisinopril ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation www hypertensiononline org SBP systolicbloodpressureDBP diastolicbloodpressure Comparedtochlorthalidone DBPsignificantlylowerinamlodipinegroup 1mmHg Comparedtochlorthalidone SBPsignificantlyhigherinamlodipine 1mmHg andlisinopril 2mmHg groups ALLHATBPControlledto 140 90mmHg Lisinopril Amlodipine Chlorthalidone www hypertensiononline org ALLHATResearchGroup JAMA 2002 288 2981 2997 PatientswithBP 140 90mmHg P 0 001foramlodipinevschlorthalidone P 0 001forlisinoprilvschlorthalidone ALLHATTreatmentandBloodPressureControl 6mos 1yr 3yr 5yr 1Drug 2Drugs 3Drugs Patients CushmanWC etal JClinHypertens 2002 4 393 405 www hypertensiononline org Average ofdrugs 1 4 1 7 2 0 1 3 ALLHATPrimaryOutcomebyTreatmentGroup CumulativeFatalCHDandNonfatalMIeventrate Timetoevent yrs 0 1 2 3 4 5 6 1525590489054 7 No atRiskChlorthalidoneAmlodipineLisinopril 1447785768535 1382082188123 1310278437711 1136268246662 634038703832 295618781770 209215195 Chlorthalidone Amlodipine Lisinopril www hypertensiononline org ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation 0 5 1 2 0 5 1 2 ALLHATCHDDeathandNonfatalMI www hypertensiononline org Favorslisinopril Favorschlorthalidone Favorsamlodipine Favorschlorthalidone ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation 0 5 1 2 0 5 2 ALLHATAll CauseMortality www hypertensiononline org Favorslisinopril Favorschlorthalidone Favorsamlodipine Favorschlorthalidone 1 ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation 0 5 2 0 5 2 ALLHATCombinedCVDisease www hypertensiononline org Favorsamlodipine Favorschlorthalidone Favorslisinopril Favorschlorthalidone 1 1 ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation ALLHATStrokebyTreatmentGroup 0 1 2 3 4 5 6 1525590489054 7 No atRiskChlorthalidoneAmlodipineLisinopril 1451586178543 1393482718172 1330979497784 1157069376765 638538453891 321718131828 567506949 Cumulativeeventrate Chlorthalidone Amlodipine Lisinopril Timetoevent yrs www hypertensiononline org ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation 0 5 1 2 0 5 2 ALLHATStroke www hypertensiononline org Favorsamlodipine Favorschlorthalidone Favorslisinopril Favorschlorthalidone 1 ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation ALLHATHeartFailurebyTreatmentGroup 0 1 2 3 4 5 6 1525590489054 7 No atRiskChlorthalidoneAmlodipineLisinopril 1452885358496 1389881858096 1322478017689 1151167856698 636937753789 301617801837 384210313 Cumulativeeventrate Chlorthalidone Amlodipine Lisinopril Timetoevent yrs www hypertensiononline org P 0 001forchlorthalidonevsamlodipineandchlorthalidonevslisinopril ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation 0 5 2 0 5 2 ALLHATHeartFailure www hypertensiononline org Favorsamlodipine Favorschlorthalidone Favorslisinopril Favorschlorthalidone 1 1 ALLHATResearchGroup JAMA 2002 288 2981 2997 Copyright 2002 AmericanMedicalAssociation ALLHATConclusions BettercontrolofsystolicBPwasachievedwithchlorthalidonethanwithamlodipineorlisinoprilTherewerenodifferencesinriskforCHDdeath nonfatalMIbetweenchlorthalidoneandamlodipineorlisinoprilInsecondaryendpoints chlorthalidonewasassociatedwithlowerriskfo
溫馨提示
- 1. 本站所有資源如無(wú)特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 統(tǒng)編版五年級(jí)語(yǔ)文下冊(cè)期末專項(xiàng)復(fù)習(xí)(積累運(yùn)用與課文理解)卷(含答案)
- 工業(yè)園區(qū)規(guī)劃與環(huán)保設(shè)計(jì)
- 工業(yè)機(jī)器人市場(chǎng)現(xiàn)狀及未來趨勢(shì)
- 工業(yè)安全與設(shè)備維護(hù)培訓(xùn)
- 工業(yè)污染源的監(jiān)測(cè)與防治技術(shù)探索
- 工業(yè)自動(dòng)化中智能硬件的角色與影響
- 工業(yè)廢熱回收與利用技術(shù)
- 工業(yè)自動(dòng)化中的數(shù)據(jù)安全與隱私保護(hù)
- 工業(yè)機(jī)器人操作與維護(hù)的實(shí)踐技巧
- 工業(yè)級(jí)智能機(jī)房的設(shè)計(jì)與施工流程
- 初中數(shù)學(xué)-專項(xiàng)24 圓內(nèi)最大張角米勒角問題
- 行政單位酒店住宿合同
- 手術(shù)器械的識(shí)別和使用方法
- 醫(yī)共體信息系統(tǒng)(HIS)需求說明
- 辦學(xué)許可證續(xù)期申請(qǐng)書
- 道路運(yùn)輸車輛的安全檢查和隱患排查
- 機(jī)械設(shè)備安裝程序、安裝分類、固定方式及安裝新技術(shù)應(yīng)用
- 大樓維修改造工程投標(biāo)方案(完整技術(shù)標(biāo))
- 取力器的設(shè)計(jì)畢業(yè)設(shè)計(jì)
- 二年級(jí)下學(xué)期語(yǔ)文無(wú)紙化測(cè)試題例
- 國(guó)際貿(mào)易實(shí)務(wù)案例分析題(附答案)2
評(píng)論
0/150
提交評(píng)論